Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Solid Tumor × talazoparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 28 Triple Negative Breast Neoplasms 12 Prostatic Neoplasms 12 Ovarian Neoplasms 10 Neoplasms 10 Neoplasm Metastasis 9 Leukemia, Myeloid, Acute 5 Fallopian Tube Neoplasms 5 Small Cell Lung Carcinoma 4 Endometrial Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Advanced Solid Tumors 4 Pancreatic Neoplasms 3 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma, Ewing 2 Recurrence 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Carcinoma, Renal Cell 2 Carcinoma, Ovarian Epithelial 2 mCRPC 1 Wilms Tumor 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Triple Negative Metastatic Breast Cancer 1 Thrombocythemia, Essential 1 Solid Tumor 1 Sarcoma 1 Rhabdomyosarcoma 1

Interventions

Injections 23 toripalimab 15 pembrolizumab 14 tislelizumab 12 Gemcitabine 8 Cisplatin 7 Carboplatin 7 atezolizumab 6 Paclitaxel 6 spartalizumab 5 Oxaliplatin 5 Leucovorin 5 Irinotecan 5 Fluorouracil 5 Bevacizumab 5 Nivolumab 4 Capecitabine 4 trastuzumab deruxtecan 3 sintilimab 3 olaparib 3 lenvatinib 3 camrelizumab 3 Pemetrexed 3 Drug Therapy 3 Docetaxel 3 Cyclophosphamide 3 Cetuximab 3 Albumin-Bound Paclitaxel 3 penpulimab 2 niraparib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04497116 2025-10-21

TRESR

Repare Therapeutics

Phase 1/2 Completed

276 enrolled 33 charts

Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡